跳至主要内容
临床试验/NL-OMON45690
NL-OMON45690已完成不适用

Visualising subdivisions of the Subthalamic Nucleus in Parkinson*s Disease with Ultra-High Field MRI <br> - PD STN connectivity UHF

Medisch Universitair Ziekenhuis Maastricht0 个研究点目标入组 100 人开始时间: 待定最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
100

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

年龄范围
18 至 64(—)

入选标准

  • Inclusion criteria for Parkinson's patients ;1. Patients must be mentally competent (Wilsbekwaam).;2. Patients must meet all requirements of the standard Scannexus screening form (see METC appendix).;3. Patients much be aged between 18 and 80 years old.;Inclusion criteria for Healthy Volunteers ;1. Healthy controls must be mentally competent (Wilsbekwaam).;2. Healthy controls must not be suffering from any neurological or psychiatric illnesses.;3. Healthy controls must meet all requirements of the standard Scannexus screening form (see METC appendix).;4. The age and gender of healthy control subjects should not significantly differ to the age and gender of the PD patients. ;5. Subjects must be aged between 18 and 80 years old.

排除标准

  • 1. Former severe head injury requiring surgery.;2. Stroke.;3. Suffering from any other non-psychiatric brain diseases. ;4. Metallic prostheses or pacemaker in the subject*s body or other contra indications for MRI. Prior to scanning, subjects will fill out a screening form (see METC appendix). This form will be sent with the information letter to all subjects. An additional form will be filled out on the day of the scan. Both are to ensure any contra indications are known to both the subject and the scanning technician.

研究者

发起方
Medisch Universitair Ziekenhuis Maastricht

相似试验

Visualising subdivisions of the Subthalamic Nucleus... | 临床试验